Monday, October 26, 2026 · Daily editionET --:--:--

Status not kept up to date

Intensity-Modulated Proton Therapy (IMPT) or TransOral Robotic Surgery (TORS) for the Treatment of Low-Risk Oropharynx Squamous Cell

NCT02663583 · M.D. Anderson Cancer Center · Updated 23 May 2019

What is being tested
Symptom Questionnaires; Dysphagia Inventory Questionnaire; Activity Bands
For
Cancer of the Mouth; Oropharynx Squamous Cell Carcinoma
Kind of study
Watches patients without assigning a treatment. No drug phase (a device or procedure study).
Who can join
Ages 18 years and older. About 44 people. The full rules are on the registry page.
Where
United States
When
Starts or started Jan 2016, ends Dec 2021. Registered 26 Jan 2016.
Results
None posted yet.

In the researchers' words

The goal of this laboratory research study is to learn about symptoms and activity levels of patients with OPSCC that receive IMPT or TORS.
ClinicalTrials.gov, NCT02663583

Sites

  • University of Texas MD Anderson Cancer CenterHouston, Texas, United States